当前,抗菌素品种已超过3,000种,应用于临床者约占其中5％。近年来我国抗菌素发展迅速,每年平均有3～4种新抗菌素研制成功,凡国外新品种,我国都可仿制。此外,我国还创制了一些新抗菌素如头孢菌素018、金褐霉素和创新霉素等。但是新抗菌素的大量涌现,也在少数人中造成了盲目“图新”甚至滥用的情况。为此,作者拟就目前国内应用的一些抗细菌抗菌素的药理与临床有关的几个问题,谈一点个人意见。 At present, there are more than 3,000 kinds of antibiotics and about 5% of them are used clinically. In recent years, the rapid development of our country’s antibiotics, an average of 3 to 4 kinds of new antibiotics developed successfully every year, where new foreign varieties, our country can be copied. In addition, our country has also created a number of new antibiotics such as cephalosporin 018, cinamycin and other antibiotics and so on. However, the massive emergence of new antibiotics has also created blind “plans for new” or even abuses among the minority. To this end, the author intends to apply some of the current domestic anti-bacterial antibiotics pharmacological and clinical issues related to a few personal opinions.